Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arcoxia for Yom Kippur headache prevention
NCT00752921Phase 4Unknown
- Sponsor
- Shaare Zedek Medical Center
- Start
- Sep 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of etoricoxib in Headache attributed to fasting, sponsored by Shaare Zedek Medical Center. Primary endpoint: Incidence of Fasting Headache at 25 hours. Status: unknown.
02
Drugs
etoricoxib
03
Conditions
Headache attributed to fasting
Beyond the preview
Go deeper on NCT00752921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00752921.